Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Polycystic Ovary Syndrome 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Mesothelioma, Malignant 1Leukemia, Myeloid, Chronic-Phase 1Immunoglobulin Light-chain Amyloidosis 1Glioblastoma 1Carcinoma, Hepatocellular 1Anxiety Disorders 1

Interventions

Cisplatin 6Platinum 5Pemetrexed 51,2-diaminocyclohexaneplatinum II citrate 5pembrolizumab 4atezolizumab 2Radiotherapy 2Radiation 2Nivolumab 2Ipilimumab 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2tremelimumab 1methoxyamine 1fludarabine 1decitabine and cedazuridine drug combination 1cediranib 1anetumab ravtansine 1aldesleukin 1Trioxsalen 1Tissue Banks 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1Pharmaceutical Preparations 1Interleukin-2 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Pharmaceutical Preparations × 90 days × Clear all
NCT07443020 2026-04-07

RIOT 4B

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Phase 1 Recruiting
10 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡